It should be emphasized that the present study is hypothesis-generating and that future studies with a larger cohort of patients are needed to address the suitability of CD163/FKBP51s+ monocyte phenotype as a powerful diagnostic tool in adjunct to MRI for the management of GBM patients. Here, CD163 is linked to glioblastoma.